Skip to main content

Gritstone bio, Inc.

GRTSDelisted Mar 5, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001656634

Gritstone bio, Inc. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on Apr 8, 2025; 56 institutions reported holding it in 13F filings for Q3 2024, worth $20.7M in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Gritstone bio, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of GRTS: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders8885−3
Shares42.1M46.9M+4.78M (+11.4%)
Value$85.9M$120.4M+$34.6M (+40.3%)

New holders (14)

Institutions that held Gritstone bio, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to GRTS in Q1 2024
InstitutionSharesValue% of portfolio
Deutsche Bank AG2,980,015$7.66M0.00%
Artal Group S.A.1,030,952$2.65M0.07%
Wellington Management Group LLP331,079$850.9K0.00%
Susquehanna Fundamental Investments, LLC247,607$636.4K0.03%
Ironwood Investment Management LLC157,603$405.0K0.20%
American Century Companies Inc93,736$240.9K0.00%
Fred Alger Management, LLC57,751$148.4K0.00%
Klingman & Associates, LLC34,786$89.4K0.01%
Two Sigma Securities, LLC29,703$76.3K0.00%
Lazard Asset Management LLC27,461$70.0K0.00%
Toroso Investments, LLC24,536$63.1K0.00%
Avantax Planning Partners, Inc.17,858$45.9K0.00%
HSBC Holdings PLC10,295$26.5K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC24$610.00%

Sold out (17)

Institutions that held Gritstone bio, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.